GlassScriptPhysician profile
Kimberly Murdock
NPI 1366716029
$3,379.66
in general payments reported to CMS, 2019-2025
33 companies · $1,437 in 2025
The $1,437 reported for 2025 was more than what 90% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $302 · 2022: $212 · 2023: $37.51 · 2024: $1,391 · 2025: $1,437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,857 · Education: $8.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,856.62 |
| Education | $8.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $382.53 | 2024-2025 | |
| Abbvie INC. | $381.84 | 2024-2025 | |
| Novo Nordisk INC | $342.18 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $337.20 | 2024-2025 | Evenity, Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $256.15 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Lilly USA, LLC | $231.24 | 2021-2025 | Mounjaro, Zepbound |
| Biohaven Pharmaceuticals, INC. | $213.26 | 2021 | |
| Palette Life Sciences, INC. | $144.85 | 2022 | |
| Revance Therapeutics, INC. | $137.71 | 2024 | Daxxify |
| Supernus Pharmaceuticals, INC. | $113.70 | 2024 | Qelbree |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.42 | 2024-2025 | Jardiance, Synjardy |
| Bayer Healthcare Pharmaceuticals INC. | $86.73 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $79.54 | 2021-2025 | Verquvo, Gardasil 9, Capvaxive |
| Corcept Therapeutics | $72.39 | 2025 | Korlym |
| Galderma Laboratories, L.P. | $70.92 | 2023-2025 | Dysport |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $53.07 | 2024 | Rexulti |
| Medtronic, INC. | $36.41 | 2025 | Kyphon Express II Kyphopak Tray |
| Glaxosmithkline, LLC. | $35.49 | 2024-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Esperion Therapeutics, INC. | $32.32 | 2022-2024 | Nexletol |
| Ardelyx, INC. | $31.30 | 2025 | Ibsrela |
| Currax Pharmaceuticals LLC | $29.15 | 2025 | Contrave, Onzetra Xsail |
| Kerecis Limited | $26.58 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Vertex Pharmaceuticals Incorporated | $24.93 | 2025 | |
| Dexcom, INC. | $24.41 | 2024 | Dexcom G6 Transmitter |
| Alkermes, INC. | $22.64 | 2025 | Vivitrol |
| Takeda Pharmaceuticals U.S.A., INC. | $19.48 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.79 | 2022 | |
| Hologic Sales and Service, LLC | $16.76 | 2022 | |
| Merz North America, INC. | $15.55 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.58 | 2024 | Xifaxan |
| Idorsia Pharmaceuticals US INC | $13.58 | 2024 | Quviviq |
| Exact Sciences Corporation | $13.29 | 2024 | Cologuard Collection Kit |
| Eisai INC. | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Murdock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.